This inventor holds 2 USPTO granted patents. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Jürgen Hess: Innovator in Tuberculosis Vaccine Development
Introduction
Jürgen Hess is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the development of vaccines. With a focus on tuberculosis, his work aims to provide protective immunity against this serious disease.
Latest Patents
Jürgen Hess holds 2 patents related to novel recombinant vaccines for tuberculosis. His latest patents describe innovative recombinant nucleic acid molecules, vectors containing these nucleic acid molecules, and cells transformed with them. These inventions are designed to enhance the immune response against tuberculosis, showcasing his commitment to advancing medical science.
Career Highlights
Hess is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a leading research institution in Germany. His work at this esteemed organization has allowed him to focus on groundbreaking research in vaccine development.
Collaborations
One of his notable collaborators is Stefan H. E. Kaufmann, with whom he has worked closely on various research projects. Their partnership has contributed to the advancement of knowledge in the field of infectious diseases.
Conclusion
Jürgen Hess is a dedicated inventor whose work in tuberculosis vaccine development is making a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to improving public health through scientific research.